Actoplus Met
- Product NDC
- 64764-310
- Requested package NDC
- 64764-310-90
- 11-digit product format
- 647640310
- Labeler code
- 64764
- Product ID
- 64764-310_12f6dfdd-309c-44a9-86bf-664c449f5ddb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pioglitazone and metformin hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Application
- NDA022024
- Marketing category
- NDA
- Marketing start
- 2010-06-11
- Marketing end
- 2022-09-30
- Substance
- PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE
- Active strength
- 30 mg/1; mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Biguanide [EPC],Biguanides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 64764-310 | 64764-310-90 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022024-001 | ACTOPLUS MET XR | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | |
| N022024-002 | ACTOPLUS MET XR | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022024-001 | 7785627 | 2026-07-31 | Drug product | ||
| N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | |
| N022024-002 | 7785627 | 2026-07-31 | Drug product | ||
| N022024-002 | 7959946 | 2026-07-31 | Drug product |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022024-001 | ACTOPLUS MET XR | 1GM;EQ 15MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022024-002 | ACTOPLUS MET XR | 1GM;EQ 30MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-05-12 | 74a2ff9319b5… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022024-001 | 7785627 | 2026-07-31 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022024-002 | 7785627 | 2026-07-31 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022024-002 | 7959946 | 2026-07-31 | Drug product | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N022024-001 | 7785627 | 2026-07-31 | Drug product | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022024-002 | 7785627 | 2026-07-31 | Drug product | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N022024-002 | 7959946 | 2026-07-31 | Drug product | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N022024-001 | 7785627 | 2026-07-31 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022024-002 | 7785627 | 2026-07-31 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N022024-002 | 7959946 | 2026-07-31 | Drug product | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022024-001 | 7785627 | 2026-07-31 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022024-002 | 7785627 | 2026-07-31 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022024-002 | 7959946 | 2026-07-31 | Drug product | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N022024-001 | 7785627 | 2026-07-31 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022024-002 | 7785627 | 2026-07-31 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N022024-002 | 7959946 | 2026-07-31 | Drug product | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022024-001 | 7785627 | 2026-07-31 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022024-002 | 7785627 | 2026-07-31 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022024-002 | 7959946 | 2026-07-31 | Drug product | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022024-001 | 7785627 | 2026-07-31 | Drug product | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022024-002 | 7785627 | 2026-07-31 | Drug product | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022024-002 | 7959946 | 2026-07-31 | Drug product | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022024-001 | 7785627 | 2026-07-31 | Drug product | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022024-002 | 7785627 | 2026-07-31 | Drug product | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022024-002 | 7959946 | 2026-07-31 | Drug product | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022024-001 | 7785627 | 2026-07-31 | Drug product | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022024-002 | 7785627 | 2026-07-31 | Drug product | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022024-002 | 7959946 | 2026-07-31 | Drug product | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022024-001 | 7785627 | 2026-07-31 | Drug product | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022024-001 | 7959946 | 2026-07-31 | Drug product | 2011-06-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022024-002 | 7785627 | 2026-07-31 | Drug product | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022024-002 | 7959946 | 2026-07-31 | Drug product | 5bbf6a4d5a75… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64764-310-30 | EA - Each | 64764-310 | 59c566a1-e1c0-4e9d-969a-cc688264d13a | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 64764-310-90 | 64764031090 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64764-310-90) | 2010-06-11 | 2022-09-30 | No | No | Current |